Skip to main content
Equibles
CUE logo

CUE · Cue Biopharma, Inc. · Short Interest

Track CUE — free

Use CUE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CUE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$16.12 -1.38 (-7.89%) At close · Nov 13 Q2 2024 earnings call transcript
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing no longer states the doubt (first flagged May 14, 2026).

View the 10-Q filed Aug 14, 2026
Market Cap
$117.10M
Shares
7.26M
Volume · Nov 13 274.96K Avg daily vol (3M) 254.21K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

CUE Latest Reported Short Interest

FINRA reported 862,798 CUE shares sold short as of the October 30, 2026 settlement date, an increase of 70,245 shares. Days to cover was 7.57 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CUE Short Interest Forecast

Equibles' model estimates 815,297 shares sold short for the November 13, 2026 settlement, -5.5% versus the latest reported position, with a likely range of 704,227 to 932,834 shares. This model prediction uses FINRA data through November 13, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 13 Low confidence 60% chance it falls
815,297 -5.5% vs reported
Likely range 704,227 to 932,834 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
68/100
Short interest 11.9% of shares — P92 Days to cover 7.6 — P81 Price vs VWAP -39.2% — P10 Short-volume trend -5.2% — P34 Short interest change +8.9% — P77 Worst FTD 1.47% of shares — P96

Positioning score 67.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-15 05:44 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-11-30 Scheduled
    FINRA publishes Dec 9
    		 — — — —
    2026-11-13 Scheduled
    FINRA publishes Nov 24
    		 — — — —
    2026-10-30 862,798 792,553 +70,245 7.57
    2026-10-15 792,553 702,198 +90,355 3.71
    2026-09-30 702,198 332,105 +370,093 1.05
    2026-09-15 332,105 318,420 +13,685 2.44
    2026-08-31 318,420 327,442 -9,022 1.76
    2026-08-14 327,442 349,876 -22,434 1.63
    2026-07-31 349,876 307,891 +41,985 1.89
    2026-07-15 307,891 298,077 +9,814 2.22
    2026-06-30 298,077 274,983 +23,094 2.68
    2026-06-15 274,983 277,694 -2,711 3.73
    2026-05-29 277,694 255,157 +22,537 2.59
    2026-05-15 255,157 288,887 -33,730 1.00
    2026-04-30 288,887 251,397 +37,490 1.00
    2026-04-15 251,397 88,817 +162,580 1.00
    2026-03-31 88,817 75,755 +13,062 1.00
    2026-03-13 75,755 59,384 +16,371 2.14
    2026-02-27 59,384 65,955 -6,571 6.07
    2026-02-13 65,955 72,177 -6,222 4.51
    2026-01-30 72,177 61,777 +10,400 1.05
    2026-01-15 61,777 48,017 +13,760 1.02
    2025-12-31 48,017 12,292 +35,725 1.00
    2025-12-15 12,292 14,727 -2,435 1.18
    2025-11-28 14,727 16,987 -2,260 2.43

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1645460 CUSIP 22978P205 13F (30d) 45 filings 34 filers Visit website Investor relations